Madam Speaker, I yield myself such time as I may consume. Madam Speaker, this issue is so important I don't think we should automatically accept a partisan proposal that doesn't even get to the heart of the problem. Today we actually could…
Madam Speaker, I yield myself such time as I may consume.
Madam Speaker, this issue is so important I don't think we should automatically accept a partisan proposal that doesn't even get to the heart of the problem.
Today we actually could be voting on H.R. 19, the Lower Costs, More Cures Act, a bipartisan bill that would not only address the root causes of the high insulin prices, but lower costs for all patients.
Instead, and I might say, very sadly, we are voting on a partisan messaging bill to give Washington a greater say in Americans' medical decisions while raising premiums on seniors and the millions of Americans with private health insurance.
This is nothing more than an attempt by my colleagues on the other side to pass just piece by piece their cures-killing Socialist takeover of the entire innovation sector. And worse, despite the misleading title of this current bill, it does nothing to lower the actual price of insulin. Instead, it uses budget games and regulations to disguise the actual cost of insulin for all consumers.
This is just another instance of misguided health and economic policies coming at a time when more than half of Americans are worried about rising prices and the economy. And, of course, like the President's budget released this week, this bill, too, is only ``paid for'' with gimmicks, adding to our deficit and the core causes of inflation.
We can and should do more for the American people who are struggling. The American people expect us to work together. We could be doing that.
Madam Speaker, I reserve the balance of my time.
Madam Speaker, I reserve the balance of my time.
Madam Speaker, I include in the Record letters from numerous groups representing and reflecting the views of millions of Americans.
AMAC Action,
Leesburg, FL, March 30, 2022.
Hon. Steve Scalise,
House Republican Whip,
Washington, DC.
Dear Whip Scalise: On behalf of the 2.3 million members of
AMAC--Association of Mature American Citizens, I write to
express our concern with H.R. 6833, the Affordable Insulin
Now Act.
Not too long ago, former President Trump made significant
gains in lowering insulin costs for Americans. He initiated
the Part D Senior Savings Model a voluntary program which
allows beneficiaries to choose enhanced Part D plan options
that offer lower out-of-pocket costs for insulin. He also
signed an Executive Order that delivered inexpensive insulin
and epinephrine to lower income patients. Unfortunately,
President Biden delayed this Executive Order the day after he
took office in 2021 before rescinding it later that year.
Now, the Democrats are considering H.R. 6833 which is an
unserious attempt to lower the price of insulin. This bill
would exert price controls on private market insulin to cap
the costs paid by patients. H.R. 6833 takes us closer to
further pharmaceutical price-fixing, a policy contained the
Build Back Better plan. Price-fixing drugs leads to rationing
and shortages as evidenced in other countries who have
employed this policy. The Democrats' bill is estimated to
increase spending by about $11 billion, and the bill is paid
for by delaying the rebate rule for one year. This Trump-era
rule compels pharmacy benefit managers to share the rebates
they receive from drug manufacturers with Part D
beneficiaries to lower their out-of-pocket expenses.
The Affordable Insulin Now Act is an election year
messaging act on the part of Democrats. If they were serious
about lowering the cost of insulin, they would work with
Republicans on innovative programs like the Part D Senior
Savings Model, a program that is expanding with robust
participation by plan sponsors and offers predictable insulin
costs that do not exceed $35/month.
As an organization comprised of Americans who are age 55-
plus, controlling drug costs, especially insulin costs, is
paramount to maintaining a good quality of life for AMAC
members. H.R. 6833 is a step in the wrong direction for
lowering insulin prices and opens the door for further
government price-fixing and regulation.
Sincerely,
Bob Carlstrom,
President, AMAC Action,
Madam Speaker, I yield such time as he may consume to the gentleman from Arizona (Mr. Schweikert), who is an expert in health policy.
Madam Speaker, it is interesting listening to the debate here. Certainly my colleague, Mr. Doggett, I think very appropriately pointed out:
This bill does not lower the price of insulin by one penny.
It just simply shifts around who pays for what.
We have seen that pattern in healthcare across America for some time now, and I would hope that we could learn from that.
Madam Speaker, I reserve the balance of my time.
Madam Speaker, I yield myself the balance of my time to close.
Madam Speaker, I think that this discussion that we are having here today is important. I also believe that we need to work together on solutions to actually reduce the cost of insulin, again, not just shifting around who pays for what. But certainly I am willing to give my colleague on the other side more information about the information Mr. Schweikert was sharing. He is very knowledgeable on the subject. He certainly works with his constituents a lot, constituents in need. And we know that literally millions of people across America are in need for lower-cost insulin. We owe them, I think, a much better approach than just simple government intrusion and more government involvement shifting around the cost.
I was a bit alarmed earlier when I heard that we should maybe make Medicare prescription coverage more like the VA. We need to remember that the VA offers roughly 50 percent of the options for participants compared to Medicare. I don't think we want to reduce the choices that seniors would have with their formularies within Medicare part D. If anything, we should make sure they have more choices. We know that more choices in the marketplace bring down the price, and we need to focus in that direction.
Madam Speaker, I urge a ``no'' vote on this bill. We owe the American people a diligent effort, working together to truly reduce the cost of insulin.
I yield back the balance of my time.